At a glance
ClinicalIndex Comparison RecordN/ACompleted· 89 enrolled
Drug / intervention
PEFS system (Product Name: Intelligent Breast Exam™ or iBE™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Utility of a Low-Cost Hand-Held Breast Scanner
In Brief
A clinical study evaluating PEFS system (Product Name: Intelligent Breast Exam™ or iBE™ for Symptomatic Breast Lump. Completed, enrolled 89 participants across 1 site.
Detailed Summary
Early detection of breast cancer improves the survival rate and makes treatment less costly. This study would measure the accuracy a low-cost hand-held commercially viable device, iBE, for the detection of clinically relevant findings in the breast using the results of current mammography as a comparison. This research will have no impact on clinical decision making.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSymptomatic Breast Lump
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
Primary CompletionJan 2016
First PostedMay 2016
Study CompletionDec 2016
TodayJul 2026
First PostedMay 5, 2016
Enrollment StartFeb 1, 2015
Primary CompletionJan 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.2 years ago
Interventions
PEFS system (Product Name: Intelligent Breast Exam™ or iBE™device